These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11017930)

  • 21. Novel method for molecular detection of the two common hereditary hemochromatosis mutations.
    Kaler SG; Devaney JM; Pettit EL; Kirshman R; Marino MA
    Genet Test; 2000; 4(2):125-9. PubMed ID: 10953951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemochromatosis in Ireland and HFE.
    Ryan E; O'keane C; Crowe J
    Blood Cells Mol Dis; 1998 Dec; 24(4):428-32. PubMed ID: 9851896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HFE based re-evaluation of heterozygous hemochromatosis.
    Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
    Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot C282Y hemochromatosis screening in Italian newborns by TaqMan technology.
    Restagno G; Gomez AM; Sbaiz L; De Gobbi M; Roetto A; Bertino E; Fabris C; Fiorucci GC; Fortina P; Camaschella C
    Genet Test; 2000; 4(2):177-81. PubMed ID: 10953958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic hemochromatosis with the mutation of Ala176Val heterozygous for HFE gene.
    Imanishi H; Liu W; Cheng J; Ikeda N; Amuro Y; Hada T
    Intern Med; 2001 Jun; 40(6):479-83. PubMed ID: 11446670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency analysis and allele map in favor of the celtic origin of the C282Y mutation of hemochromatosis.
    Lucotte G
    Blood Cells Mol Dis; 2001; 27(2):549-56. PubMed ID: 11500066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in the HFE gene.
    Douabin V; Moirand R; Jouanolle A; Brissot P; Le Gall J; Deugnier Y; David V
    Hum Hered; 1999 Jan; 49(1):21-6. PubMed ID: 9858853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HFE genotyping using multiplex allele-specific polymerase chain reaction and capillary electrophoresis.
    Lubin IM; Yamada NA; Stansel RM; Pace RG; Rohlfs EM; Silverman LM
    Arch Pathol Lab Med; 1999 Dec; 123(12):1177-81. PubMed ID: 10583922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of an unlabeled probe melting analysis assay combined with high-throughput extractions for genotyping of the most common variants in HFE-associated hereditary hemochromatosis, C282Y, H63D, and S65C.
    Sumner K; Hubley L; Pont-Kingdon G; Mitchell S; Wayman T; Wilson A; Meadows C; Elenitoba-Johnson K; Pattison D; Dobrowolski S; Best H; Lyon E
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):656-60. PubMed ID: 22364140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of C282Y and H63D in the HFE gene.
    Pointon JJ; Merryweather-Clarke AT; Carella M; Robson KJ
    Genet Test; 2000; 4(2):115-20. PubMed ID: 10953949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of the hemochromatosis C282Y and H63D mutations in a Polish population of Slavic origin.
    Moczulski DK; Grzeszczak W; Gawlik B
    Med Sci Monit; 2001; 7(3):441-3. PubMed ID: 11386022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis.
    Distante S; Berg JP; Lande K; Haug E; Bell H
    Gut; 2000 Oct; 47(4):575-9. PubMed ID: 10986220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic hemochromatosis, a Celtic disease: is it now time for population screening?
    Byrnes V; Ryan E; Barrett S; Kenny P; Mayne P; Crowe J
    Genet Test; 2001; 5(2):127-30. PubMed ID: 11551098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Noll WW; Belloni DR; Stenzel TT; Grody WW
    Nat Genet; 1999 Nov; 23(3):271-2. PubMed ID: 10610176
    [No Abstract]   [Full Text] [Related]  

  • 36. Overestimation of HFE C282Y homozygous hemochromatosis prevalence as the result of a common primer-binding site polymorphism.
    Press RD
    Mol Diagn; 1999 Dec; 4(4):391-2. PubMed ID: 10671650
    [No Abstract]   [Full Text] [Related]  

  • 37. Celtic origin of the C282Y mutation of hemochromatosis.
    Lucotte G
    Blood Cells Mol Dis; 1998 Dec; 24(4):433-8. PubMed ID: 9851897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A primer for predicting risk of disease in HFE-linked hemochromatosis.
    Adams PC; Walker AP; Acton RT
    Genet Test; 2001; 5(4):311-6. PubMed ID: 11960576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete scanning of the hereditary hemochromatosis gene (HFE) by use of denaturing HPLC.
    Le Gac G; Mura C; Férec C
    Clin Chem; 2001 Sep; 47(9):1633-40. PubMed ID: 11514397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary hemochromatosis: the clinical significance of the S65C mutation.
    Asberg A; Thorstensen K; Hveem K; Bjerve KS
    Genet Test; 2002; 6(1):59-62. PubMed ID: 12180078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.